Pharmaceutical Expert Recognized as 2015 Honored Alumnus
Jeffrey Jasper (B.S., Chemistry, 1984) is the 2015 Honored Alumnus in the College of Science & Mathematics. Jasper is vice president of preclinical sciences at Revolution Medicines and has more than 20 years experience in the pharmaceutical industry. His areas of expertise include molecular pharmacology and preclinical drug development in the areas of neuromuscular, gastrointestinal and respiratory diseases.
After earning his doctorate in pharmacology at UCSD’s School of Medicine and completing his postdoctoral training at Stanford, Jasper worked for several pharmaceutical companies, including Merck & Co., Roche, and Theravance. At Theravance — and in collaboration with GlaxoSmithKline — he helped develop the medicine Breo Ellipta, now marketed for the treatment of chronic obstructive pulmonary diseases, such as emphysema. Also at Theravance, he contributed to two respiratory disease medicines now in late-stage clinical development.
Jasper went on to co-found Altos Therapeutics, a specialty company devoted to developing pharmaceuticals for gastrointestinal (GI) disorders for which few or no treatments are currently available.
Jasper has served for more than 18 years as a member of the editorial board for the American Journal of Physiology and has published 50 scientific articles in peer-reviewed journals.